by Burl Gilyard – August 10, 2016
Plymouth-based Rotation Medical Inc. has raised $8 million in a new round of financing, according to a Tuesday filing with the U.S. Securities and Exchange Commission.
The company’s Rotation Medical Rotator Cuff Repair System treats rotator cuff disease with it’s a unique implant that helps the body grow new tendon-like tissue. The product secured approval from the U.S. Food and Drug Administration in 2014. In the new filing, Rotation Medical declined to disclose its revenue.
The company has a solid track record of attracting investors. In July 2014, the company announced that it had raised $27.2 million in Series B financing to support the commercial launch and post-market clinical studies of its product. Including its latest round, SEC filings indicate that Rotation Medical has raised about $49 million since 2010.
Martha Shadan, an executive with extensive experience in the medial device industry, joined Rotation Medical as its president and CEO in 2013. Shadan could not be reached for comment.
